MD Anderson Cancer Center has signed an agreement with the International Atomic Energy Agency to become an IAEA Collaborating Centre.
Thirty six early-career investigators received the the American Society of Hematology 2024 Scholar Awards.
CANCER TREATMENT CENTERS OF AMERICA and the National Football League Alumni Association announced a new partnership to raise awareness among NFL alumni and fans about screening, diagnosis and treatment for prostate cancer. The partnership also calls for CTCA to treat NFL alumni who are fighting the disease.
Shikhar Mehrotra, professor of surgery and Cecilia and Vincent Peng Endowed Chair in melanoma and cutaneous oncology, will take on the role of co-leader of the Cancer Biology and Immunology Research Program at MUSC Hollings Cancer Center, alongside Philip Howe, professor and chair of the Department of Biochemistry & Molecular Biology, and Sophie Paczesny, professor in the Department of Microbiology & Immunology.
Alexandra Miller, a neurologist and neuro-oncologist specializing in treating primary brain tumors, has been named as the chief of the Division of Neuro-Oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, effective Jan. 29.
A research team from Louisiana State University LCMC Health Cancer Center has been awarded a $1.5 million grant to eliminate barriers from cervical cancer prevention.
Stacyann Bailey, assistant professor of biomedical engineering at the University of Massachusetts Amherst, has received a two-year grant from NCI to study the complex relationship between drugs used to treat metastatic cancer and the development of bone damage.
The American Association for Cancer Research has elected the 2023 class of fellows of the AACR Academy.
Kelly J. Norsworthy was named acting associate director for research mentorship in FDA’s Oncology Center of Excellence.
The Mark Foundation for Cancer Research awarded five new Emerging Leader Awards, totaling $3.75 million, to early-career investigators for projects aimed at addressing unmet needs in cancer research.
